Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Jing Xu

机构:Tongji University, University of Science and Technology of China, Peking University, Biotechnology Research Center, Changchun Institute of Applied Chemistry, Beike Biotechnology (China), Shanghai Tenth People's Hospital, Peking University Third Hospital · ORCID:0009-0008-0689-7783

发表论文 43 篇 · 总被引 240 次 · h-index 5

代表论文

  • A multi-level multi-task progressive framework based on relational graph convolutional networks for causal emotion entailment (2024 · Knowledge-Based Systems · 被引 5)
  • Application of nanoscale CeO2 as Fenton-like catalyst in the field of environment and bioscience (2025 · Chinese Journal of Analytical Chemistry · 被引 4)
  • Secondary Acute Myeloid Leukemia Following Chemotherapy for Angioimmunoblastic T-Cell Lymphoma (2025 · Clinical Laboratory · 被引 2)
  • De novo patients with high-volume metastatic hormone-sensitive prostate cancer can benefit from the addition of docetaxel to triplet therapy: Network-analysis and systematic review (2024 · Chinese Medical Journal · 被引 1)
  • Figure 3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study (2025)
  • Supplementary Table S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study (2025)